Hematological predictive markers for recurrent or metastatic squamous cell carcinomas of the head and neck treated with nivolumab: A multicenter study of 88 patients.

Takashi MatsukiIsaku OkamotoChihiro FushimiMichi SawabeDaisuke KawakitaHiroki SatoKiyoaki TsukaharaTakahito KondoTakuro OkadaYuichiro TadaKouki MiuraGo OmuraTaku Yamashita

Published in: Cancer medicine (2020)

Pretreatment NLR and mGPS might be predictive markers of survival in patients with R/M SCCHN treated with nivolumab.

Keyphrases

newly diagnosed
squamous cell
end stage renal disease
ejection fraction
chronic kidney disease
squamous cell carcinoma
small cell lung cancer
patient reported outcomes
free survival
patient reported